Testosterone Cypionate Injectable Recalled Due to Lack of Sterility Assurance
Drug Depot, Inc. is recalling 620 vials of Testosterone Cypionate/DHEA injectables due to lack of sterility assurance in manufacturing. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable product with a lack of sterility assurance, which constitutes a risk-of-harm product. No illnesses or injuries have been reported. Per the rubric, risk-of-harm products where injury has not yet been reported are classified as High (3).
Plain-English summary
Drug Depot, Inc., doing business as APS Pharmacy, is recalling 620 vials of Testosterone Cypionate/DHEA 200/10 mg/mL Injectable due to lack of sterility assurance. The recalled product consists of multi-dose 10 mL vials available in two formulations: Formula ID 115678 (Lot 746000, use-by date 6/26/2022) and Formula ID 115498 (Lot 751472, use-by date 7/20/2022).
The affected product was distributed nationwide in the United States, including Puerto Rico. Lack of sterility assurance means the manufacturing process did not ensure the product is free from microbial contamination, which could pose a risk of serious infection to users who receive injections from these vials.
If you have this product, do not use it. Consult your healthcare provider or pharmacist for guidance on safe disposal and obtaining a replacement. Report any adverse health effects to the FDA's MedWatch program at 1-888-SAFEFDA.
The recalled product
- Product
- TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy
- Manufacturer
- Drug Depot, Inc., dba APS Pharmacy
- Category
- Drug — Injectable / Testosterone
- Affected units
- 620
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: a)746000 BUD: 6/26/2022
- b) 751472 BUD: 7/20/2022
Distribution
Part of a larger recall action
This product is one of 8 recalled by Drug Depot, Inc., dba APS Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Drug Depot, Inc., dba APS Pharmacy
See all →- HighTestosterone Cypionate Injectable Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-04-06
- HighInjectable testosterone-anastrozole mixture recalled for sterility assurance failure
FDA (Drugs) · 2022-04-06
- HighTestosterone Cypionate/Anastrozole Injectable Recalled for Sterility Assurance Defect
FDA (Drugs) · 2022-04-06
- HighFDA Recalls Gonadorelin Injectable Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-04-06
- HighInjectable Testosterone Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-04-06
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15